Episode
Intro: Triple Negative Breast Cancer and the role of Immunotherapy.
- Published
- Feb 23, 2024
- Duration seconds
- 181
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/nursing-excellence-in-cancer-care-cancer-nurses-society-of-australia-podcast-6586861/episodes/intro-triple-negative-breast-cancer-and-the-role-of-immunotherapy/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/nursing-excellence-in-cancer-care-cancer-nurses-society-of-australia-podcast-6586861/intro-triple-negative-breast-cancer-and-the-role-of-immunotherapy.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
This is an introduction the latest episode Podcast, where we discuss Triple Negative Breast Cancer and the role of IO therapy. Jenny Gilchrist, a Nurse Practitioner in Breast Oncology at Macquarie University Health Services Centre and Chief Clinical Lead for the Metastatic McGrath Breast Cancer nurses, is joined by Melanie Rabbets, Clinical Nurse Practitioner at Blacktown Hospital. . This podcast must be accessed via the member portal at https://www.cnsa.org.au/congressevents/podcast CNSA has big plans for the next twelve months, with over 30 webinars scheduled; Breast Cancer, Management and Educator Communities of Practice tackling relevant and practical topics; and of course the Annual Congress in June. Jemma Still, Chief Executive Officer Cancer Nurses Society of Australia give a brief insight into what is coming for 2024.